Skip to main content
Dermatology Practical & Conceptual logoLink to Dermatology Practical & Conceptual
. 2025 Jan 30;15(1):4566. doi: 10.5826/dpc.1404a4566

Correlation of Psychosomatic Factors and Personality Traits with The Severity of Hidradenitis Suppurativa

Konstantinos Kontoangelos 1,2,, Foteini Dionysia Foulou 1, Sofia Tsiori 1, Charalabos Papageorgiou 2, Alexander Stratigos 3, Aikaterini I Liakou 3
PMCID: PMC11928126  PMID: 40117646

Abstract

Introduction

Hidradenitis suppurativa is a disease with a decisive burden on sufferers, both physical and psychological. It was expected that the more intense the severity of symptoms the patients experienced, the greater the correlation with the psychosomatic manifestations would be.

Objectives

The present study aimed to explore the correlation between hidradenitis suppurativa and the psychosomatic burden, the personality, and the demographic characteristics of the participants.

Methods

The participants were 90 outpatients of the hospital, aged 18 to 65, who had been diagnosed with hidradenitis and were sufficiently proficient in Greek. The psychometric instruments administered were the Symptom Checklist-90 (SCL90), the Beck Depression Inventory (BDI), the Eysenck Personality Questionnaire (EPQ), the short-form McGill Pain Questionnaire (SF-MPQ), the Hurley and refined Hurley classifications, the International Hidradenitis Suppurativa Severity Scoring System (IHS4), and a short demographic questionnaire. All statistical analyses were performed using the SPSS-28 statistical package.

Results

According to statistical analyses, there was no statistically significant relationship between disease severity, psychosomatic burden, and personality. However, there were statistically significant associations with demographic factors, such as being female or not being in a relationship, the patient’s body mass index, the locus of the skin lesion, a history of hospitalization, comorbidities, psychiatric history, and pain with psychopathological manifestations and personality.

Conclusions

It is important that further research be conducted that will include more mental disorders besides anxiety and depression while at the same time excluding confounding factors for safer interpretation of the results.

Keywords: Factitious disorder, Depression, Psychosomatic, Pain, Psychodermatology

Introduction

The human body as a whole is covered by the skin, thus making it the most visible organ of the body. Therefore, any problem that appears on the skin can potentially affect the mental health of the person [1]. One of the diseases that cause intense skin changes and that have been linked to a multitude of mental disorders is hidradenitis suppurativa (HS) [2]. Undoubtedly, based on the international literature, the most frequently studied aspect of diffuse hidradenitis is the positive correlation between anxiety and depression in patients [3]. Patients with HS present high rates of psychopathology which are related to the nature of the disease (the intense pain and the foul-smelling secretions that make the person’s daily life difficult), as a result of which they refrain from their activities and are gradually led to isolation, which by definition is a risk factor for depression [4,5]. Psychosocial vulnerability in HS patients is related to the psychological disability and financial burden it creates, in addition to physical problems [6], and HS patients also display a significantly inferior quality of life as well as worse anxiety and depression symptomatology when compared to patients with alopecia, mild-to-moderate psoriasis, and various other dermatological diseases [79]. Apart from the brain-skin connection, in the literature there are reports of common behavioral habits (e.g., smoking) among those suffering from HS and mental disorders [1012]. Another common behavior of HS and mental illness sufferers is substance abuse and alcohol consumption. Patients with HS commonly use cannabis, opioids, and alcohol in order to reduce the anxiety or the pain they experience as a result of the disease [13]. In the literature, there is a connection between dermatological diseases and obsessive-compulsive disorder [14]. A possible explanation given by the researchers is that people who suffer from obsessive-compulsive disorder, compared to the general population, visit health professionals more often, as a result of which they receive more diagnoses in all diseases, therefore also in dermatological ones [15,16]. Another important element that burdens the psychology of patients with HS is pain [17,18]. Chronic pain usually occurs in people with an advanced stage of the disease, and the sensation is described as pulsating, creating heightened sensitivity [19,20].

Objectives

In the present study, the correlation between the severity of hidradenitis suppurativa and psychosomatic burden with personality and pain was investigated. Whether demographic factors correlate with psychopathological manifestations and personality traits was also examined.

Methods

The sample of the study included outpatients of the Andreas Syggros Hospital who had received a diagnosis of hidradenitis suppurativa (HS). More specifically, 90 patients with HS participated; the majority were males (N=48), making up 53.3% of the total, compared to females (N=42), who formed the remaining 46.7%. In terms of the age distribution, the participants ranged in age from 18 to 65 years old. The range of age at disease onset was from two to 43, with a mean value of 12.6 years, and in 77.7% of participants (N=70), there was a large discrepancy between the date of onset of the disease and the date of diagnosis. In fact, 71.1% (N=64) had visited several medical specialties, such as general surgeons, plastic surgeons, gynecologists, and dermatologists, before they received the correct diagnosis. Additionally, regarding the site part of the physical damage, the majority had genital damage (N=72) at a percentage of 80.0%, while 43.3% (ν=39) had damages in the anus or buttocks (N=39), 13.5% in inframammary fold, and only 5.6% (N=5) showing the disease on the face; 100% of the sample had at least two foci of infection from the disease. When the assessment was performed, 48.8% (N=44) scored Hurley II on the severity scale, 31.1% (N=28) had Hurley III, and 20% (N=18) had Hurley I. Regarding co-morbidity, only 40.0% (N=36) had accompanying diseases simultaneously to hidradenitis. Also, a minority of the patients had a psychiatric history at a rate of 26.7% (N=24), of which the most frequently occurring mental disorders were depression (N=16) and symptoms of anxiety (N=5).

Research Process

The questionnaires were completed anonymously. The participants were informed about the purposes of the study and their participation was voluntary, while at the same time anonymity and confidentiality were respected. The entire process was entirely governed by the principles of the Code of Ethics & Conduct.

Means of Data Collection

Brief Demographic Information Questionnaire: Information was requested regarding age, sex, weight, smoking, employment, education level, marital status, number of children, place of birth origin, place of residence, co-morbidity with other diseases, date of disease onset, date of diagnosis, the medical specialties visited, the part of the body where there was a skin lesion, the treatment they had received for hidradenitis, the existence of hospitalization for the disease, the Hurley, refined Hurley, and International Hidradenitis Suppurativa Severity Scoring System (IHS4) scores, the existence of psychiatric history, diagnosis, taking medication, and whether they were undergoing psychotherapy.

The Symptom Checklist-90 (SCL-90) [21] is a self-completed questionnaire that measures nine psychopathology parameters (as many as its subscales): (1) somatization; (2) depression; (3) anxiety; (4) phobic anxiety; (5) obsessive compulsive; (6) paranoid ideation; (7) psychoticism; (8) hostility; (9) interpersonal sensitivity. The questionnaire includes a total of 90 questions [22].

The Beck Depression Inventory (BDI) is a 21-question multiple-choice self-assessment report inventory, one of the most widely used instruments for measuring the severity of depression. Its development marked a shift among healthcare professionals, who had until then viewed depression from a psychodynamic perspective, instead of it being rooted in the patient’s own thoughts [23].

The Eysenck Personality Questionnaire (EPQ) [24] is a psychometric personality scale that consists of 84 items evaluated by the patient with a yes or no answer. The purpose of this questionnaire is to explore four dimensions of personality: psychoticism (P), neuroticism (N) extraversion (E), and lying (L) [25].

The main component of the short-form McGill Pain Questionnaire (SF-MPQ) consists of 15 descriptors (11 sensory; four 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate, or 3 = severe. Three pain scores are derived from the sum of the intensity rank values of the words chosen for sensory, affective, and total descriptors [26].

In order to calculate the severity of (HS), dermatologists evaluate patients with three scales: Hurley, refined Hurley, and IHS4. The Hurley scale consists of three subtypes (I, II, and III) [27]. Finally, the IHS4 is a validated tool for the dynamic assessment of HS severity, correlates with the Hurley classification, and can be used both in real life and in a clinical trial setting [28].

Statistical Analysis

The descriptive characteristics and Cronbach’s alpha measure of the psychometric tools are presented in Table 1, where most of the scales have excellent or good reliability level, whereas only the scale of psychoticism and lying lie of the personality questionnaire have acceptable or questionable levels.

Table 1.

Descriptive Characteristics and Reliability Coefficients for BDI, SCL90, and EPQ.

Psychometric scales Mean SD Minimum Maximum Cronbach’s Alpha
BDI 13.10 10.99 0 46 0.93
SCL90 Somatization 0.76 0.98 0 4 0.95
Obsessive-compulsive 0.00 0.00 0 0 0.97
Interpersonal sensitivity 0.00 0.00 0 0 0.95
Depression 15.48 11.15 0 42 0.97
Anxiety 8.77 7.59 0 29 0.95
Hostility 5.53 4.89 0 23 0.85
Phobic anxiety 3.39 5.08 0 20 0.97
Paranoid ideation 4.83 4.71 0 20 0.90
Psychoticism 5.18 5.98 0 24 0.85
EPQ Psychoticism 4.62 2.40 1 12 0.70
Neuroticism 12.12 5.72 1 22 0.81
Extraversion 12.52 4.60 1 19 0.81
Lying Lie 9.44 4.02 1 18 0.65

Abbreviations: Mean: mean value, SD: standard deviation, Min: minimum, Max: maximum, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL-90: Symptom Checklist

Comparing the psychometric scales with the sex of the patients, it turns out that females diagnosed with hidradenitis had on average a higher score than did males in a multitude of variables. More specifically, females scored on average statistically significantly higher than males in BDI (mean: 16.17, SD: 12.20 vs. mean: 10.42, SD: 9.11, P = 0.020), in somatization (mean: 12.40, SD: 10.04 vs. mean: 6.33, SD: 7.98, P = 0.002), in obsessive-compulsive (mean: 12.38, SD: 9.26 vs. mean: 8.31. SD: 6.54, P = 0.046), in the interpersonal sensitivity (mean: 9.81, SD: 8.59 vs. mean: 5.42 SD: 4.54, P = 0.018), in depression (mean: 17.55, SD: 12.59 vs. mean: 11.23, SD: 8.33, P = 0.032), in anxiety (mean: 9.98, SD: 8.99 vs. mean: 5.25, SD: 4.76, P = 0.040), and in phobic anxiety (mean: 4.60, SD: 6.17 vs. mean: 1.29, SD: 2.20, P = 0.002). The results are given in Table 2.

Table 2.

Mean, Standard Deviation of the Psychometric Scales by Patient Sex.

Psychometric scales Sex U-value P
Male Female
Mean SD Mean SD
BDI BDI 10.42 9.11 16.17 12.20 720.00 0.020
SCL90 Somatization 6.33 7.98 12.40 10.04 626.50 0.002
Obsessive-compulsive 8.31 6.54 12.38 9.26 761.50 0.046
Interpersonal sensitivity 5.42 4.54 9.81 8.59 715.50 0.018
Depression 11.23 8.33 17.55 12.59 743.50 0.032
Anxiety 5.25 4.76 9.98 8.99 754.50 0.040
Hostility 4.35 4.48 5.02 5.39 968.50 0.747
Phobic anxiety 1.29 2.20 4.60 6.17 650.00 0.002
Paranoid ideation 3.69 3.26 5.81 5.88 873.50 0.273
Psychoticism 3.65 4.57 6.62 6.92 782.50 0.066
EPQ Psychoticism 4.52 2.25 4.74 2.59 989.50 0.880
Neuroticism 11.25 5.93 13.12 5.37 845.00 0.186
Extraversion Introversion 13.13 4.52 11.83 4.65 844.00 0.183
Lying Lie 8.92 3.74 10.05 4.29 847.50 0.192

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90.

Moreover, it was examined whether family structure correlated with psychopathological symptoms and personality. Patients who were without a partner (either single, divorced, or widowed) had on average a statistically significantly higher score on the anxiety scale compared to the patients who were married or under cohabitation agreement (mean: 8.00, SD: 7.02 vs. mean: 6.37, SD: 7.83, P = 0.046, Table 3).

Table 3.

Mean, Standard Deviation of the Psychometric Scales by the Patients’ Family Status.

Psychometric scales Family status U-value P
Not married/Divorced/ Widowed Married/Cohabitation agreement
Mean SD Mean SD
BDI 13.70 11.77 12.19 9.79 946.00 0.830
SCL90 Somatization 7.70 7.65 9.60 10.57 722.00 0.758
Obsessive compulsive 10.00 7.68 9.89 8.11 723.00 0.767
Interpersonal sensitivity 7.70 6.97 6.80 6.91 651.00 0.306
Depression 13.35 9.32 13.91 11.43 722.00 0.759
Anxiety 8.00 7.02 6.37 7.83 554.50 0.046
Hostility 4.42 3.64 5.06 6.36 687.50 0.510
Phobic anxiety 3.40 4.95 2.37 4.91 583.50 0.074
Paranoid ideation 4.26 4.35 4.77 4.89 721.00 0.750
Psychoticism 4.84 5.39 4.74 5.91 691.00 0.533
EPQ Psychoticism 4.78 2.60 4.39 2.09 927.00 0.708
Neuroticism 12.15 6.07 12.08 5.24 966.00 0.961
Extraversion Introversion 12.56 4.99 12.47 4.01 934.00 0.754
Lying Lie 9.35 4.37 9.58 3.50 924.50 0.694

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory ; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90.

According to Table 4, patients who were overweight or obese compared to patients with a normal weight had higher scores on the scales of interpersonal sensitivity (mean: 8.29, SD: 8.06 and mean: 8.91, SD: 7.26 vs. mean: 4.48, SD: 4.18, P = 0.031) and of paranoid ideation (mean: 5.39, SD: 4.39 and mean: 5.79, SD: 5.90 vs. mean: 2.28, SD: 1.95, P = 0.024).

Table 4.

Mean, Standard Deviation of the Psychometric Scales by Patients’ Body Mass Index.

Psychometric scales Body Mass Index Kruskal-Wallis H P
Normal Overweight Obese
Mean SD Mean SD Mean SD
BDI 8.92 7.91 15.39 12.97 14.09 10.39 4.59 0.101
SCL90 Somatization 6.08 6.42 10.58 10.44 10.15 10.10 2.98 0.226
Obsessive compulsive 6.92 4.75 10.81 9.57 12.09 8.17 5.25 0.073
Interpersonal sensitivity 4.48 4.18 8.29 8.06 8.91 7.26 6.97 0.031
Depression 10.00 7.23 15.42 11.89 16.12 11.74 4.20 0.123
Anxiety 5.12 4.64 7.61 7.86 9.03 8.34 2.55 0.279
Hostility 3.12 3.37 4.00 3.55 6.41 6.31 4.46 0.108
Phobic anxiety 1.88 3.79 3.13 5.40 3.26 4.86 2.32 0.313
Paranoid ideation 2.28 1.95 5.39 4.39 5.79 5.90 7.49 0.024
Psychoticism 2.64 3.49 6.06 7.03 5.85 5.96 4.99 0.083
EPQ Psychoticism 4.76 2.92 4.52 2.50 4.62 1.91 0.25 0.882
Neuroticism 10.36 4.66 13.03 6.00 12.59 6.03 4.41 0.110
Extraversion 13.48 3.03 12.55 5.21 11.79 4.95 1.38 0.501
Lying Lie 9.80 3.67 8.81 3.68 9.76 4.57 1.20 0.550

Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist.

Patients who had lesions in the armpit had statistically significantly more extroversion symptoms compared to patients who did not have physical lesions in the armpit (mean: 13.79, SD: 4.64 vs. mean: 11.42, SD: 4.32, P = 0.008, Table 5). On the other hand, patients who had damage to the anus or buttocks had on average a statistically significantly lower score on the extraversion scale than patients who did not have damage on anus or buttocks (mean: 11.15, SD: 4.75 vs. mean: 13.57, SD: 4.24, P = 0.017, Table 6).

Table 5.

Means Standard Deviation of the Psychometric Scales by Damage in Axilla.

Psychometric scales Axilla U-value P
No Yes
Mean SD Mean SD
BDI 13.38 10.97 12.79 11.13 953.50 0.659
SCL90 Somatization 9.19 10.00 9.14 8.92 968.00 0.746
Obsessive-compulsive 9.94 8.51 10.52 7.79 933.50 0.546
Interpersonal sensitivity 7.44 7.72 7.50 6.29 912.50 0.438
Depression 14.88 11.19 13.38 10.73 950.00 0.639
Anxiety 7.33 7.95 7.60 6.83 905.50 0.406
Hostility 4.19 5.02 5.21 4.78 824.00 0.133
Phobic anxiety 3.19 5.58 2.43 3.69 965.50 0.717
Paranoid ideation 4.44 4.88 4.95 4.67 886.50 0.322
Psychoticism 4.94 6.34 5.14 5.53 915.00 0.448
EPQ Psychoticism 4.23 2.38 5.07 2.37 779.00 0.061
Neuroticism 12.67 5.31 11.50 6.17 915.00 0.451
Extraversion 11.42 4.32 13.79 4.64 683.00 0.008
Lying Lie 9.79 3.72 9.05 4.36 904.00 0.398

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire.

Table 6.

Means Standard Deviation of the Psychometric Scales by Damage in Anus or Buttocks.

Psychometric scales Anus / buttocks U-value P
No Yes
Mean SD Mean SD
BDI 11.98 10.00 14.56 12.14 883.50 0.365
SCL90 Somatization
Obsessive-compulsive 9.45 8.50 8.79 10.68 872.00 0.317
Interpersonal sensitivity 9.90 6.77 10.62 9.73 961.50 0.788
Depression 6.76 6.18 8.38 8.04 906.00 0.470
Anxiety 13.31 10.29 15.31 11.77 906.00 0.471
Hostility 7.71 6.85 7.13 8.16 878.00 0.341
Phobic anxiety 4.69 4.62 4.64 5.32 939.00 0.648
Paranoid ideation 2.76 4.11 2.92 5.59 909.00 0.463
Psychoticism 4.18 4.13 5.33 5.47 899.00 0.434
EPQ Psychoticism 4.67 2.16 4.56 2.71 936.50 0.633
Neuroticism 11.41 5.84 13.05 5.50 828.50 0.176
Extraversion 13.57 4.24 11.15 4.75 703.00 0.017
Lying Lie 9.63 4.15 9.21 3.89 924.00 0.564

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck;s Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire.

Hospitalized patients had a statistically significantly lower score on the BDI depression scale (mean: 6.09, SD: 7.16 vs. mean: 14.08, SD: 11.10, P = 0.011), of somatization (mean: 4.09, SD: 5.26 vs. mean: 9.87, SD: 9.71, P = 0.031), of interpersonal sensitivity (mean: 3.73, SD: 3.41 vs. mean: 7.99, SD: 7.28, P = 0.045), SCL90 depression (mean: 8.27, SD: 7.48 vs. mean: 15.00, SD: 11.13, P = 0.041), and neuroticism (mean: 8.36, SD: 5.78 vs. mean: 12.65, SD: 5.55, P = 0.020), and higher scores on the extroversion scale (mean: 16.27, SD: 1.85 vs. mean: 12.00, SD: 4.63, P =0.002, Table 7).

Table 7.

Means, Standard Deviation of the Psychometric Scales by Patient Hospitalization.

Psychometric scales Hospitalization for hidradenitis U-value P
No Yes
Mean SD Mean SD
BDI 14.08 11.10 6.09 7.16 229.00 0.011
SCL90 Somatization 9.87 9.71 4.09 5.26 260.00 0.031
Obsessive compulsive 10.72 8.27 6.55 6.27 299.00 0.095
Interpersonal sensitivity 7.99 7.28 3.73 3.41 274.50 0.048
Depression 15.00 11.13 8.27 7.48 269.00 0.041
Anxiety 7.87 7.73 4.45 3.39 353.00 0.314
Hostility 4.78 5.06 3.82 3.74 393.50 0.610
Phobic anxiety 3.13 5.02 0.73 1.19 309.00 0.103
Paranoid ideation 5.01 4.92 2.27 2.33 290.50 0.074
Psychoticism 5.38 6.11 2.55 3.96 285.00 0.063
EPQ Psychoticism 4.61 2.46 4.73 2.05 402.50 0.690
Neuroticism 12.65 5.55 8.36 5.78 246.00 0.020
Extraversion 12.00 4.63 16.27 1.85 186.50 0.002
Lying Lie 9.23 3.90 11.00 4.71 330.00 0.196

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90.

Patients who had comorbidities had on average statistically significantly higher scores on the obsessive-compulsive scale (mean: 12.58, SD: 8.75 vs. mean: 8.63, SD: 7.37, P = 0.018), of paranoid ideation (mean: 6.22, SD: 5.66 vs. mean: 3.65, SD: 3.77, P = 0.037), and psychoticism (mean: 6.53, SD: 6.46 vs. mean: 4.04, SD: 5.41, P = 0.020, Table 8).

Table 8.

Means, Standard Deviation of the psychometric scales by the existence of comorbidities.

Psychometric scales Comorbidities U-Value P
No Yes
Mean SD Mean SD
BDI 11.69 9.80 15.22 12.41 807.00 0.173
SCL90 Somatization 7.89 8.86 11.08 10.10 780.50 0.114
Obsessive compulsive 8.63 7.37 12.58 8.75 686.50 0.018
Interpersonal sensitivity 6.33 5.97 9.17 8.22 759.50 0.079
Depression 12.76 10.44 16.31 11.47 788.50 0.130
Anxiety 6.83 7.09 8.39 7.87 821.50 0.214
Hostility 3.96 4.00 5.72 5.92 821.00 0.209
Phobic anxiety 2.44 3.96 3.42 5.81 928.00 0.703
Paranoid ideation 3.65 3.77 6.22 5.66 720.00 0.037
Psychoticism 4.04 5.41 6.53 6.46 691.50 0.020
EPQ Psychoticism 4.37 2.40 5.00 2.39 815.00 0.191
Neuroticism 11.87 5.65 12.50 5.89 905.50 0.583
Extraversion 12.43 4.58 12.67 4.69 942.00 0.804
Lying Lie 9.76 3.78 8.97 4.37 873.00 0.413

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90.

The existence of a psychiatric history in patients suffering from hidradenitis affected most psychiatric scales. Patients with a psychiatric history had statistically significantly higher scores on the BDI scale compared to those without a psychiatric history (mean: 22.96, SD: 13.24 vs. mean: 9.52, SD: 7.37, P <0.001) and in all SCL90 psychopathology scales. Regarding the personality scales, patients with a psychiatric history scored statistically significantly higher on the scale of psychoticism (mean: 5.75, SD: 2.47 vs. mean: 4.21, SD :2.26, P = 0.007) and neuroticism (mean: 15.58, SD: 5.67 vs. mean: 10.86, SD: 5.23, P <0.001), while scoring statistically significantly lower on the extraversion scale (mean: 10.58, SD: 5.41 vs. mean: 13.23, SD: 4.09, P = 0.029, Table 9).

Table 9.

Means, Standard Deviation of the Psychometric Scales by the Psychiatric History.

Psychometric scales Psychiatric history U-Value P
No Yes
Mean SD Mean SD
BDI 9.52 7.37 22.96 13.24 318.00 <0.001
SCL90 Somatization 6.68 6.98 16.00 11.90 413.50 0.001
Obsessive compulsive 7.82 5.77 16.79 10.03 368.50 <0.001
Interpersonal sensitivity 5.20 4.27 13.71 9.24 347.00 <0.001
Depression 10.86 7.85 23.29 13.07 364.00 <0.001
Anxiety 4.92 4.54 14.42 9.23 335.50 <0.001
Hostility 3.68 3.80 7.38 6.47 522.50 0.013
Phobic anxiety 1.18 1.75 7.38 7.09 357.00 <0.001
Paranoid ideation 3.29 3.60 8.50 5.51 357.00 <0.001
Psychoticism 3.17 3.47 10.17 8.08 357.00 <0.001
EPQ Psychoticism 4.21 2.26 5.75 2.47 500.00 0.007
Neuroticism 10.86 5.23 15.58 5.67 407.00 <0.001
Extraversion 13.23 4.09 10.58 5.41 554.00 0.029
Lying Lie 9.58 3.65 9.08 4.99 723.50 0.530

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire.

The correlation between patients’ psychometric scales and their age, the age at onset of the disease, the duration of the disease, and the pain scale are presented in Table 10. The pain scale seemed to influence the scores of the patients on the psychometric scales, since the BDI scale of depression is statistically significantly related with a positive correlation coefficient with the pain scale (r=0.65, P <0.001). The pain scale is statistically significantly related to the scales of somatization (r=0.32, P = 0.002), obsessive compulsive (r=0.26, P = 0.014), interpersonal sensitivity (r=0.43, P <0.001), depression (r=0.50, P <0.001), anxiety (r=0.31, P = 0.003), phobic anxiety (r=0.32, P = 0.002), paranoid ideation (r=0.35, P = 0.001), and psychoticism (r=0.37, P <0.001) with positive correlation coefficients. Therefore, patients who experienced more pain also scored higher on the corresponding scales. In addition, the pain scale was statistically significantly related to the neuroticism scale (r=0.46, P <0.001, Table 10).

Table 10.

Spearman Correlation Coefficient between the Psychometric Scales and Patients’ Age, the Age at Onset of the Disease, the Duration of the Disease, and the Pain Scale.

Age Age at the onset of disease Duration of the disease Pain
Cor. Coef. p Cor. Coef. p Cor. Coef. p Cor. Coef. P
BDI 0.04 0.69 −0.02 0.876 −0.08 0.468 0.65 <0.001
SCL90 Somatization 0.06 0.587 −0.002 0.982 0.13 0.236 0.32 0.002
Obsessive compulsive −0.04 0.700 0.06 0.549 0.05 0.614 0.26 0.014
Interpersonal sensitivity −0.10 0.350 −0.06 0.602 −0.02 0.873 0.43 <0.001
Depression 0.002 0.986 0.02 0.864 −0.05 0.656 0.50 <0.001
Anxiety −0.06 0.598 0.07 0.512 −0.04 0.704 0.31 0.003
Hostility −0.04 0.726 0.01 0.945 0.02 0.869 0.13 0.220
Phobic anxiety −0.18 0.083 −0.08 0.473 −0.09 0.381 0.32 0.002
Paranoid ideation 0.08 0.485 0.03 0.811 0.02 0.886 0.35 0.001
Psychoticism −0.09 0.382 −0.06 0.608 0.03 0.773 0.37 <0.001
EPQ Psychoticism 0.10 0.375 0.03 0.763 0.09 0.419 0.10 0.368
Neuroticism 0.02 0.846 0.07 0.545 0.02 0.850 0.46 <0.001
Extraversion 0.04 0.688 −0.04 0.747 0.10 0.359 −0.15 0.159
Lying Lie 0.002 0.984 0.01 0.914 −0.01 0.961 −0.20 0.062

Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire.

Discussion

The purpose of the present study was to investigate the correlation between psychosomatic parameters, personality, and demographic data and the severity of hidradenitis suppurativa. As can be seen from the results, there was no correlation between the severity of the disease and the psychosomatic manifestations. This correlation is contrary to the existing literature. As was expected, the more severe damage the sufferers had (Hurley III), the higher their score in psychosomatic disorders [29,30]. A possible explanation for this finding is that the patients’ mental state seemed to be affected more by the perception they had of the disease and the consequences it would have on their lives than by the severity of the disease itself, as reflected by the dermatologists’ Hurley, defined Hurley, and IHS4 scales [31].

The statistical analysis showed that females were more burdened with depression, interpersonal sensitivity, anxiety, phobic anxiety, somatization, and compulsiveness. It appears that females suffering from HS show more frequent symptoms of anxiety and depression [32,33]. However, in a more recent study [34], there were no differences between the two sexes in terms of psychopathological manifestations.

Regarding body mass index, it was found that overweight and obese patients, in contrast with normal weight patients, had statistically significantly higher scores on the scales of interpersonal sensitivity and paranoid ideation. One possible explanation for the association with interpersonal sensitivity and paranoid ideation may be the constant recommendation by dermatologists to lose weight, as obesity is one of the main factors that negatively affects the progression of the disease [35], while it may also be a causative factor [36]. Additionally, the part of the body where the patients showed skin damage was correlated with the extraversion variable in the personality scale. Lesions in the armpit were associated with higher extraversion scores, while, on the contrary, those with genital, anal, or gluteal lesions had a significantly lower score on the extraversion scale. At the same time, no differences were observed in those with lower mammary lesions. This may be because having damage to the genitals and anus can result in avoidance of sexual contact. Even the damaged area, in combination with a wrong diagnosis by specialists, can be misinterpreted as a sexually transmitted disease, with the result that these individuals are isolated from interactions, experiencing fear and social stigmatization [37], and also because skin damage is accompanied by a strong odor, which further complicates everyday life [38].

Significant connections were also found with patients who had comorbidities. These people showed higher scores on the obsessive-compulsive, paranoid ideation, and psychoticism scales. The connection between obsessive compulsive disorder and individuals experiencing various organic diseases is well known, as is the emphasis patients place on physical changes, psychologically exhausting themselves by repeatedly visiting doctors and receiving more diagnoses of all diseases in comparison with the general population [15]. Moreover, endocrine disorders, in addition to anxiety and depression, have also been positively associated with psychotic symptoms [39]. Psychiatric history was also examined, which appeared to be positively correlated with all variables of psychosomatic burden, psychoticism, and neuroticism, while there was a negative correlation with the extraversion variable. From this analysis it appears that psychiatric history was perhaps a variable with the highest statistically significant correlations in the psychosomatic burden and in the personality scale, which can significantly increase the possibility that someone will develop a mental disorder [40]. It is worth noting that the question that the participants were asked was whether they had a psychiatric history, without specifying whether it predated the disease or whether it appeared due to the burden of the disease. In any case, the mental state of the sufferers should be assessed, and they should receive appropriate help immediately. Furthermore, the psychiatric history variable positively correlated with the personality psychoticism scale, which, according to the developers of the EPQ, measures obsessive-compulsiveness and neuroticism similar to histrionic personality. This could be because there is a high comorbidity between dermatological disorders and obsessive-compulsive personality, regardless of age for both sexes [15].

Additionally, the pain scale correlated statistically significantly with depression, anxiety, anger, paranoid ideation, psychoticism, and the neuroticism variable from the personality scale. Based on the literature, it was expected that the longer the time between the date of onset and the age at diagnosis of the disease, the greater the burden on the patients would be, because they would have symptoms of hidradenitis without knowing what diseases they had nor would they have received the appropriate treatment, although this was not confirmed by the present study [41]. An explanation could be that all patients had a large discrepancy between the onset and diagnosis of the disease, therefore the data were homogeneous, and this is why there were no statistically significant differences. Additionally, the lack of a relationship may be due to the fact that when the sample was taken, all patients were receiving appropriate treatment and had adequate knowledge of the disease, so any mental or physical burden they had felt in the past would have been compensated for at the time of the study, and they would not have responded while being burdened. Regarding pain and its correlation with most scales of psychopathology, this is an expected outcome as, based on the international literature, pain is among the most important problems of HS patients [17], since it affects up to 97% of patients [18]. In fact, painful and smelly abscesses contribute to low self-esteem, avoidance of social interaction, and feelings of hopelessness, which trigger the appearance of psychopathology [42]. Meanwhile, the correlation with the neuroticism scale identified with histrionic personality could be due to the acting-out behaviors that are the structural feature of the disorder, something which may be triggered by pain. In any case, due to the absence of research, further investigation is needed.

Conclusion

As can be seen from the present study and from the previous ones, there should be better education, both in the medical community and in the general population, because sufferers endure for many years the symptoms of a disease they cannot identify and receive inappropriate treatments due to both dermatologists’ and other medical specialties’ not making a correct differential diagnosis.

Footnotes

Competing Interests: None.

Authorship: All authors have contributed significantly to this publication.

Funding: None.

References

  • 1.Fabrazzo M, Cipolla S, Signoriello S, et al. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. J Eur Psychiatry. 2021 Nov 25;64(1):e71. doi: 10.1192/j.eurpsy.2021.2249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5):S19–S22. doi: 10.1016/j.jaad.2015.07.054. [DOI] [PubMed] [Google Scholar]
  • 3.Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539–561. doi: 10.1016/j.jaad.2008.11.911. [DOI] [PubMed] [Google Scholar]
  • 4.Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29(2):371–376. doi: 10.1111/jdv.12567. [DOI] [PubMed] [Google Scholar]
  • 5.Sabat R, Jemec GB, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020 Mar 12;6(1):18. doi: 10.1038/s41572-020-0149-1. [DOI] [PubMed] [Google Scholar]
  • 6.Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539–561. doi: 10.1016/j.jaad.2008.11.911. [DOI] [PubMed] [Google Scholar]
  • 7.Patel KR, Lee HH, Rastogi S, et al. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;83(3):737–744. doi: 10.1016/j.jaad.2019.11.068. [DOI] [PubMed] [Google Scholar]
  • 8.de Souza DF, Wartchow K, Hansen F, et al. Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:14–22. doi: 10.1016/j.pnpbp.2012.12.001. [DOI] [PubMed] [Google Scholar]
  • 9.Van der Zee HH, de Ruiter L, Van Den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011;164(6):1292–1298. doi: 10.1111/j.1365-2133.2011.10254.x. [DOI] [PubMed] [Google Scholar]
  • 10.Kohorst JJ, Kimball AB, Davis MD. Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5):S27–S35. doi: 10.1016/j.jaad.2015.07.055. [DOI] [PubMed] [Google Scholar]
  • 11.König A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198(3):261–264. doi: 10.1159/000018126. [DOI] [PubMed] [Google Scholar]
  • 12.Mackowick KM, Barr MS, Wing VC, Rabin RA, Ouellet-Plamondon C, George TP. Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. Prog Neuropsychopharmacol Biol Psychiatry. 2014;52:79–85. doi: 10.1016/j.pnpbp.2013.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Caccavale S, Tancredi V, Boccellino MP, Babino G, Fulgione E, Argenziano G. Hidradenitis Suppurativa Burdens on Mental Health: A Literature Review of Associated Psychiatric Disorders and Their Pathogenesis. Life. 2023;13(1):189. doi: 10.3390/life13010189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. 2013. [DOI] [Google Scholar]
  • 15.Chou YJ, Tai YH, Dai YX, et al. Obsessive–compulsive disorder and the associated risk of autoimmune skin diseases: a nationwide population-based cohort study. CNS Spectr. 2023;28(2):157–163. doi: 10.1017/S1092852921000973. [DOI] [PubMed] [Google Scholar]
  • 16.Phan K, Huo Y R, Smith SD. Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: systematic review and meta-analysis. Ann Transl Med. 2020;8(13):821. doi: 10.21037/atm-20-1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Krajewski PK, Matusiak L, Von Stebut E, et al. Pain in hidradenitis suppurativa: a cross-sectional study of 1,795 patients. Acta Derm Venereol. 2021;101(1) doi: 10.2340/00015555-3724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Matusiak Ł, Szczęch J, Kaaz K, Lelonek E, Szepietowski JC. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venereol. 2018;98(2):191–194. doi: 10.2340/00015555-2815. [DOI] [PubMed] [Google Scholar]
  • 19.Puza CJ, Wolfe SA, Jaleel T. Pain management in patients with hidradenitis suppurativa requiring surgery. Dermatologic Surgery. 2019;45(10):1327–1330. doi: 10.1097/DSS.0000000000001693. [DOI] [PubMed] [Google Scholar]
  • 20.Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Archives of internal medicine. 2003;163(20):2433–2445. doi: 10.1001/archinte.163.20.2433. [DOI] [PubMed] [Google Scholar]
  • 21.Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595–605. [PubMed] [Google Scholar]
  • 22.Donias S, Karastergiou A, Manos N. Validation of the Symptom Checklist-90-R in Greek Population. Psychiatriki. 1991;2:42–48. doi: 10.5431/aramit0209. [DOI] [Google Scholar]
  • 23.Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004. [DOI] [PubMed] [Google Scholar]
  • 24.Eysenck HJ, Eysenck SBG. Manual of the EPQ (Personality Questionnaire) Hodder and Stoughton Educational. Hodder & Stoughton Educational; London, UK: 1975. [Google Scholar]
  • 25.Dimitriou E. EPQ Personality Questionnaire. Greek Validation in the Greek Population Dimitriou E. Engefalos. 1986;23:41–54. [Google Scholar]
  • 26.Melzack R. The short-form McGill Pain Questionnaire. Pain. 1975;1(3):277–299. doi: 10.1016/0304-3959(75)90044-5. [DOI] [PubMed] [Google Scholar]
  • 27.Horváth B, Janse IC, Blok JL, et al. Hurley staging refined: a proposal by the Dutch Hidradenitis Suppurativa Expert Group. Acta Derm Venereol. 2017;97(3):412–413. doi: 10.2340/00015555-2513. [DOI] [PubMed] [Google Scholar]
  • 28.Zouboulis CC, Tzellos T, Kyrgidis A, et al. European Hidradenitis Suppurativa Foundation Investigator Group Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017;177(5):1401–1409. doi: 10.1111/bjd.15748. [DOI] [PubMed] [Google Scholar]
  • 29.Carniciu S, Hafi B, Gkini MA, Tzellos T, Jafferany M, Stamu-O’Brien C. Secondary psychiatric disorders and the skin. Dermatological Reviews. 2023;4(4):162–171. doi: 10.1002/der2.211. [DOI] [Google Scholar]
  • 30.Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91(3):328–332. doi: 10.2340/00015555-1082. [DOI] [PubMed] [Google Scholar]
  • 31.Onderdijk AJ, Van der Zee HH, Esmann S, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473–478. doi: 10.1111/j.1468-3083.2012.04468.x. [DOI] [PubMed] [Google Scholar]
  • 32.Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29(2):371–376. doi: 10.1111/jdv.12567. [DOI] [PubMed] [Google Scholar]
  • 33.Huilaja L, Tiri H, Jokelainen J, Timonen M, Tasanen K. Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study. J Invest Dermatology. 2018;138(1):46–51. doi: 10.1016/j.jid.2017.06.020. [DOI] [PubMed] [Google Scholar]
  • 34.Rymaszewska J, Krajewski P, Szczęch J, Szepietowski J. Depression and anxiety in hidradenitis suppurativa patients: A cross-sectional study among Polish patients. Postępy Dermatol Alergol. 2022;39(1) doi: 10.5114/ada.2022.119080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol. 2020;183(6):999–1010. doi: 10.1111/bjd.19556. [DOI] [PubMed] [Google Scholar]
  • 36.Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18. doi: 10.1038/s41572-020-0149-1. Published 2020 Mar 12. [DOI] [PubMed] [Google Scholar]
  • 37.Kouris A, Platsidaki E, Christodoulou C, et al. Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa. Dermatology. 2016;232(6):687–691. doi: 10.1159/00045335. [DOI] [PubMed] [Google Scholar]
  • 38.Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5):S19–S22. doi: 10.1016/j.jaad.2015.07.054. [DOI] [PubMed] [Google Scholar]
  • 39.Aslan S, Ersoy R, Kuruoglu AC, Karakoc A, Cakir N. Psychiatric symptoms and diagnoses in thyroid disorders: a cross-sectional study. Int J Psychiatry in Clinical Practice. 2005;9(3):187–192. doi: 10.1080/13651500510029129. [DOI] [PubMed] [Google Scholar]
  • 40.Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71(6):1144–1150. doi: 10.1016/j.jaad.2014.09.012. [DOI] [PubMed] [Google Scholar]
  • 41.Saunte DM, Boer J, Stratigos A. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015 Dec;173(6):1546–9. doi: 10.1111/bjd.14038. Epub 2015 Nov 3. [DOI] [PubMed] [Google Scholar]
  • 42.Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014;90(1062):216–221. doi: 10.1136/postgradmedj-2013-131994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Dermatology Practical & Conceptual are provided here courtesy of Mattioli 1885

RESOURCES